- Home
- WNW vs THTX Comparison
WNW vs THTX Comparison
Compare WNW & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- THTX
- Stock Information
- Founded
- WNW 2015
- THTX 1993
- Country
- WNW China
- THTX Canada
- Employees
- WNW N/A
- THTX N/A
- Industry
- WNW Catalog/Specialty Distribution
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- THTX Health Care
- Exchange
- WNW Nasdaq
- THTX Nasdaq
- Market Cap
- WNW 49.2M
- THTX 54.3M
- IPO Year
- WNW 2020
- THTX N/A
- Fundamental
- Price
- WNW $1.64
- THTX $1.79
- Analyst Decision
- WNW
- THTX Hold
- Analyst Count
- WNW 0
- THTX 1
- Target Price
- WNW N/A
- THTX N/A
- AVG Volume (30 Days)
- WNW 355.2K
- THTX 85.1K
- Earning Date
- WNW 12-24-2024
- THTX 10-10-2024
- Dividend Yield
- WNW N/A
- THTX N/A
- EPS Growth
- WNW N/A
- THTX N/A
- EPS
- WNW N/A
- THTX N/A
- Revenue
- WNW $380,345.00
- THTX $84,316,000.00
- Revenue This Year
- WNW N/A
- THTX $5.60
- Revenue Next Year
- WNW N/A
- THTX $4.62
- P/E Ratio
- WNW N/A
- THTX N/A
- Revenue Growth
- WNW N/A
- THTX 5.75
- 52 Week Low
- WNW $0.71
- THTX $1.08
- 52 Week High
- WNW $11.11
- THTX $2.58
- Technical
- Relative Strength Index (RSI)
- WNW 75.09
- THTX 70.56
- Support Level
- WNW $0.91
- THTX $1.40
- Resistance Level
- WNW $1.68
- THTX $1.56
- Average True Range (ATR)
- WNW 0.15
- THTX 0.12
- MACD
- WNW 0.05
- THTX 0.03
- Stochastic Oscillator
- WNW 78.63
- THTX 96.65
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.